Bioinformatics analysis showed that MAFG-AS1 expression was elevated in prostate cancer compared with normal prostate tissue and was higher in more advanced prostate cancer, indicating that MAFG-AS1 is a diagnostic biomarker for prostate cancer. This evidence concerns the gene MAFG and prostate carcinoma.